TITLE

Hermes

PUB. DATE
December 2017
SOURCE
Pediatric Radiology;Dec2017, Vol. 47 Issue 13, p1853
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
126306224

 

Related Articles

  • Increased Incidence of Incomplete Kawasaki Disease at a Pediatric Hospital After Publication of the 2004 American Heart Association Guidelines. Ghelani, Sunil; Sable, Craig; Wiedermann, Bernhard; Spurney, Christopher // Pediatric Cardiology;Oct2012, Vol. 33 Issue 7, p1097 

    We sought to study the impact of the 2004 American Heart Association guidelines on diagnosis and treatment of patients with Kawasaki disease (KD). We reviewed patient records from July 2000 to June 2002 (group 1) and July 2007 to June 2009 (group 2) at a tertiary children's hospital. The...

  • Identification and treatment of Kawasaki disease. Sadovsky, Richard // American Family Physician;7/1/1998, Vol. 58 Issue 1, p223 

    Present a summary of the article `Kawaski Disease. The Mystery Continues,' by D.J. Bradley and M.P. Glode, published in the 1998 issue of the journal `Western Journal of Medicine'. Identification of the three phases of the disease; Information on the characteristic laboratory findings; Symptoms...

  • New Perspectives in the Drug Treatment of Kawasaki Disease. Shingadia, D.; Shulman, S.T. // Pediatric Drugs;Oct-Dec1999, Vol. 1 Issue 4, p291 

    Kawasaki disease (KD) has become the leading cause of acquired heart disease in developed countries. Conventional therapy for KD includes intravenous gammaglobulin (2 g/kg as a single dose over 12 hours) and aspirin (acetylsalicylic acid; high dose until the fourteenth day of illness then low...

  • Combined treatment appears effective for patients with Kawasaki disease.  // Infectious Diseases in Children;Jan2012, Vol. 25 Issue 1, p14 

    The author cites a study conducted at Kitasato University School of Medicine in Japan indicating combined intravenous methylprednisolone pulse and intravenous immunoglobulin an effective treatment for patients with Kawasaki disease noting, however, the unclear applicability of the data to...

  • Risk stratification may help guide KD treatment decisions.  // Infectious Diseases in Children;Jul2009, Vol. 22 Issue 7, p19 

    The article discusses research being done on intravenous immunoglobulin and prednisolone and Kawasaki disease treatment, referencing a study by Tohru Kobayashi et al, published in a 2009 issue of "Pediatric Infectious Disease Journal."

  • Kawasaki Disease. Taubert, Kathryn A.; Shulman, Stanford T. // American Family Physician;6/1/1999, Vol. 59 Issue 11, p3093 

    Provides information on Kawasaki disease, a leading cause of acquired heart disease among children in the United States. Epidemiology; Diagnostic criteria of Kawasaki disease; Etiology and diagnosis; Clinical and laboratory findings; Treatment.

  • Comparison of High-Dose and Low0Dose Aspirin Plus Intravenous Immunoglobulin in the treatment of Kawasaki Syndrome. Saulsbury, Frank T. // Clinical Pediatrics;Oct2002, Vol. 41 Issue 8, p597 

    The efficacy of intravenous immunoglobulin (IVIG) in the treatment of Kawasaki syndrome (KS) has been unequivocally established, but questions remain concerning the proper dose of adjunctive aspirin therapy in the treatment of KS. The medical records of 72 children with KS were reviewed. All...

  • Kinetic Analysis of Co-stimulatory and Co-inhibitory Molecules: A New Approach to the Treatment of Kawasaki Disease. Narazaki, Hidehiko // Journal of Nippon Medical School;2012, Vol. 79 Issue 1, p95 

    An abstract of a lecture on the kinetic analysis of co-stimulatory and inhibitory bio-molecules for the treatment of Kawasaki disease, delivered at the 79th annual meeting of the Medical Association of Nippon Medical School in Tokyo, Japan on September 3, 2011 is presented.

  • Editorial comment. Corbeel, Lucien // European Journal of Pediatrics. Supplement;2007, Vol. 166, p91 

    The authors discuss various studies which focused on Kawasaki disease (KD). All the studies discussed the use of intravenous gamma globulin (IVIG) in treating giant coronary aneurysm associated with KD. They showed that most patients with KD responded well to IVIG. The authors also notes other...

  • KAWASAKI DISEASE (SYNDROME). Chowdary, V. Sathavahana; Kumar, E. C. Vinay; Rao, V. Koteswara; Rani, R. Sudha // Indian Journal of Otolaryngology & Head & Neck Surgery;Jan-Mar2007, Vol. 59 Issue 1, p68 

    Kawasaki disease also known as mucocutaneous lymph node syndrome is a generalised vasculitis of unknown etiology. Presenting a review of the literature and using our cases for illustration we discuss some of the pertinent features in the evaluation and management of patients with this condition....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics